153 related articles for article (PubMed ID: 28345842)
1. Bone Mineral Density in Survivors of Childhood Acute Lymphoblastic Leukemia.
Rohani F; Arjmandi Rafsanjani Kh; Bahoush G; Sabzehparvar M; Ahmadi M
Asian Pac J Cancer Prev; 2017 Feb; 18(2):535-540. PubMed ID: 28345842
[TBL] [Abstract][Full Text] [Related]
2. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors.
Geneviève N; Mojgan Y; Nahid Y; Vincenzo F; Simon G; Daniel S; Maja K; Nathalie A; Despoina M
J Bone Miner Res; 2024 Mar; 39(2):130-138. PubMed ID: 38477791
[TBL] [Abstract][Full Text] [Related]
3. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D
Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106
[TBL] [Abstract][Full Text] [Related]
5. Little evidence of low bone mass in acute lymphoblastic leukemia survivors.
Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J
J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524
[TBL] [Abstract][Full Text] [Related]
6. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
7. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health.
Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS
Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650
[TBL] [Abstract][Full Text] [Related]
8. Does the combination of quantitative ultrasound and dual-energy X-ray absorptiometry improve fracture discrimination?
Frost ML; Blake GM; Fogelman I
Osteoporos Int; 2001; 12(6):471-7. PubMed ID: 11446563
[TBL] [Abstract][Full Text] [Related]
9. Predictors of bony morbidity in children with acute lymphoblastic leukemia.
Rayar MS; Nayiager T; Webber CE; Barr RD; Athale UH
Pediatr Blood Cancer; 2012 Jul; 59(1):77-82. PubMed ID: 22190454
[TBL] [Abstract][Full Text] [Related]
10. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA
J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of monthly ibandronate in men with low bone density.
Orwoll ES; Binkley NC; Lewiecki EM; Gruntmanis U; Fries MA; Dasic G
Bone; 2010 Apr; 46(4):970-6. PubMed ID: 20060082
[TBL] [Abstract][Full Text] [Related]
12. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood.
van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM
Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472
[TBL] [Abstract][Full Text] [Related]
13. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study.
Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J
Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009
[TBL] [Abstract][Full Text] [Related]
14. Contribution of Lumbar Spine BMD to Fracture Risk in Individuals With T-Score Discordance.
Alarkawi D; Bliuc D; Nguyen TV; Eisman JA; Center JR
J Bone Miner Res; 2016 Feb; 31(2):274-80. PubMed ID: 26241926
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density and biochemical markers of bone metabolism in predialysis patients with chronic kidney disease.
Fidan N; Inci A; Coban M; Ulman C; Kursat S
J Investig Med; 2016 Apr; 64(4):861-6. PubMed ID: 26969749
[TBL] [Abstract][Full Text] [Related]
16. A Validated Risk Prediction Model for Bone Fragility in Children With Acute Lymphoblastic Leukemia.
Verwaaijen EJ; Ma J; de Groot-Kruseman HA; Pieters R; van der Sluis IM; van Atteveld JE; Halton J; Fernandez CV; Hartman A; de Jonge R; Lequin MH; Te Winkel ML; Alos N; Atkinson SA; Barr R; Grant RM; Hay J; Huber AM; Ho J; Jaremko J; Koujok K; Lang B; Matzinger MA; Shenouda N; Rauch F; Rodd C; van den Heuvel-Eibrink MM; Pluijm SMF; Ward LM;
J Bone Miner Res; 2021 Dec; 36(12):2290-2299. PubMed ID: 34610647
[TBL] [Abstract][Full Text] [Related]
17. Bone mineral density in long-term survivors of childhood cancer.
Hesseling PB; Hough SF; Nel ED; van Riet FA; Beneke T; Wessels G
Int J Cancer Suppl; 1998; 11():44-7. PubMed ID: 9876477
[TBL] [Abstract][Full Text] [Related]
18. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia].
Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M
Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments.
Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N
Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587
[TBL] [Abstract][Full Text] [Related]
20. Reductions in Bone Mineral Density Are Apparent Early in Children With Prevalent Osteonecrosis Lesions Following Leukemia Therapy.
Halton JM; Ma J; Babyn P; Matzinger MA; Kaste SC; Scharke M; Fernandez CV; Miettunen P; Ho J; Alos N; Abish S; Barr R; Cairney E; Dix DB; Grant RM; Israels S; Lewis V; Wilson B; Atkinson S; Cabral D; Cummings E; Rodd C; Stein R; Sbrocchi AM; Jaremko JL; Koujok K; Shenouda N; Rauch F; Siminoski K; Ward LM;
J Bone Miner Res; 2023 Aug; 38(8):1104-1115. PubMed ID: 37326443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
